Skip to main content

Table 2 Comparison of clinical characteristics and endocrine parameters in PCOS and non-PCOS patients for miRNA analysis

From: Hsa_circ_0043532 contributes to PCOS through upregulation of CYP19A1 by acting as a ceRNA for hsa-miR-1270

Basic parameters

PCOS (n = 14)

non-PCOS (n = 18)

p-values

Age (years)

31.4 ± 1.5

31.4 ± 1.9

NS

Infertility duration(yr)

3.8 ± 2.1

3.3 ± 1.9

NS

BMI (kg/m2)

25.7 ± 3.3

23.1 ± 3.7

 < 0.05

FSH (mIU/ml)

6.01 ± 0.90

6.66 ± 1.22

NS

LH (mIU/ml)

11.66 ± 4.61

5.19 ± 2.25

 < 0.0001

LH/FSH

1.93 ± 0.70

0.77 ± 0.26

 < 0.0001

PRL (ng/ml)

14.78 ± 5.91

18.61 ± 6.37

 < 0.05

P (ng/ml)

0.29 ± 0.13

0.44 ± 0.18

NS

AMH (ng/ml)

11.64 ± 6.43

4.54 ± 2.95

 < 0.0001

E2 (pg/ml)

48.65 ± 26.65

42.76 ± 20.91

NS

T (ng/ml)

0.59 ± 0.11

0.29 ± 0.09

 < 0.0001

FBG (mmol/L)

5.03 ± 0.40

4.73 ± 0.35

NS

Antral follicle count

34.33 ± 13.72

17.56 ± 6.65

 < 0.0001

oocytes obtained

16.78 ± 6.78

13.66 ± 6.44

 < 0.0001

Embryo ratea

0.47 ± 0.23

0.47 ± 0.19

NS

  1. Data are presented as the mean ± SD, p < 0.05 is considered to be statistically significant
  2. BMI body mass inde, FSH follicle-stimulating hormone, LH luteinizing hormone, PRL prolactin, P Progesterone, AMH anti-Müllerian hormone, E2 estradiol, T testosterone, FBG Fasting blood glucose
  3. aEmbryo rate = number of embryos/oocytes obtained